Search results for " MDR"

showing 4 items of 14 documents

Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells

2005

Pterostilbene and 3,5-hydroxypterostilbene are the natural 3,5-dimethoxy analogs of trans-resveratrol and piceatannol, two compounds which can induce apoptosis in tumor cells. In previous studies we demonstrated the importance of a 3,5-dimethoxy motif in conferring pro-apoptotic activity to stilbene based compounds so we now wanted to evaluate the ability of pterostilbene and 3,5-hydroxypterostilbene in inducing apoptosis in sensitive and resistant leukemia cells. When tested in sensitive cell lines, HL60 and HUT78, 3'-hydroxypterostilbene was 50-97 times more potent than trans-resveratrol in inducing apoptosis, while pterostilbene appeared barely active. However, both compounds, but not tr…

PiceatannolLeukemiaPterostilbeneABLHL60ApoptosisCell BiologyGenes ablBiologyBiochemistrystilbenes leukemia BCR-ABL multidrug resistance apoptosischemistry.chemical_compoundImatinib mesylatePhenolsBiochemistrychemistryApoptosisCell cultureCell Line TumorStilbenesCancer researchHumansfas ReceptorGenes MDRStem cellThe International Journal of Biochemistry & Cell Biology
researchProduct

Characterization of the first extended-spectrum beta-lactamase-producing nontyphoidal Salmonella strains isolated in Tehran, Iran.

2009

The infections caused by Salmonella remain a significant public health problem throughout the world. beta-Lactams and fluoroquinolones are generally used to treat invasive Salmonella infections, but emergence and spread of antibiotic-resistant strains are being increasingly notified in many countries. In particular, detection of extended-spectrum beta-lactamases (ESBLs) in Salmonella spp. is a newly emerging threat worldwide. This study was carried out to characterize beta-lactamase-producing Salmonella strains identified in Tehran, Iran. Over the 2-year period from 2007 to 2008, 6 of 136 Salmonella isolates recovered from pediatrics patients, including three Salmonella enterica serotypes E…

Serotypemedicine.medical_specialtySalmonellamedicine.medical_treatmentMolecular Sequence DataDrug resistanceMicrobial Sensitivity TestsBiologyIranmedicine.disease_causeApplied Microbiology and BiotechnologyMicrobiologyPolymerase Chain Reactionbeta-LactamasesMicrobiologylaw.inventionSpecies SpecificitylawSalmonellaMolecular geneticsDrug Resistance Multiple BacterialmedicineHumansS. enteritidisSerotypingChildPolymerase chain reactionInfantSequence Analysis DNAbiology.organism_classificationVirologyPhenotypeAmino Acid SubstitutionSalmonella enteritidisSalmonella entericaChild PreschoolConjugation GeneticSalmonella InfectionsBeta-lactamaseAnimal Science and ZoologyGenes MDRFood ScienceFoodborne pathogens and disease
researchProduct

Bloodstream infections in intensive care unit patients: Distribution and antibiotic resistance of bacteria

2015

Vincenzo Russotto,1 Andrea Cortegiani,1 Giorgio Graziano,2 Laura Saporito,2 Santi Maurizio Raineri,1 Caterina Mammina,2 Antonino Giarratano1 1Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anaesthesia, Analgesia, Intensive Care and Emergency, Paolo Giaccone University Hospital, University of Palermo, Palermo, Italy; 2Department of Sciences for Health Promotion and Mother-Child Care, University of Palermo, Palermo, Italy Abstract: Bloodstream infections (BSIs) are among the leading infections in critically ill patients. The case-fatality rate associated with BSIs in patients admitted to intensive care units (ICUs) reaches 35%–50%. The emergence and diffusi…

medicine.medical_specialtybloodstream infectionsmedicine.drug_classAntibioticsICU; MDR; antibiotic; bloodstream infections; intensive care unit; multidrug resistantSettore MED/41 - AnestesiologiaReviewBloodstream infectionmedicine.disease_causelcsh:Infectious and parasitic diseaseslaw.inventionAntibiotic resistancelawIntensive careEpidemiologyMDRmedicinelcsh:RC109-216Pharmacology (medical)Intensive care unitMED/41 - ANESTESIOLOGIAIntensive care medicinePharmacologybiologybusiness.industryAntibioticAcinetobacterbiology.organism_classificationIntensive care unitMultiple drug resistanceInfectious DiseasesMultidrug resistantStaphylococcus aureusICUAntibiotic; Bloodstream infections; ICU; Intensive care unit; MDR; Multidrug resistantbusiness
researchProduct

SORVEGLIANZA DELLE COLONIZZAZIONI DA STAPHYLOCOCCUS AUREUS METICILLINO-RESISTENTE E GRAM-NEGATIVI MULTI-RESISTENTI NELLE UNITA’ DI TERAPIA INTENSIVA …

2014

INTRODUZIONE: La diffusione della resistenza batterica, sia in ospedale che in comunità, costituisce un serio motivo di allarme. La disseminazione di microrganismi resistenti in ospedale, particolarmente accentuata in reparti critici quali le terapie intensive, è favorita oltre che dall’uso dei farmaci antimicrobici, da procedure chirurgiche e/o invasive, dalla presenza di pazienti compromessi e dal trasferimento da una struttura sanitaria ad un’altra di pazienti colonizzati o infetti. Una conoscenza dettagliata dell’entità del fenomeno e dei principali microrganismi antibiotico-resistenti in ambito nosocomiale è essenziale per lo sviluppo di strategie volte a prevenire tale fenomeno. In qu…

terapia intensiva neonataleantibiotico-resistenzaSettore MED/38 - Pediatria Generale E SpecialisticaUTINStaphylococcus aureuSettore MED/42 - Igiene Generale E ApplicataMRSA MDRGN
researchProduct